Phreesia Net Profit Margin 2019-2025 | PHR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Phreesia net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Phreesia net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.7B
Hims & Hers Health (HIMS)	$13B
Doximity (DOCS)	$11.5B
Tempus AI (TEM)	$11.2B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.9B
Hinge Health (HNGE)	$3.7B
Privia Health (PRVA)	$2.5B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.7B
10x Genomics (TXG)	$1.7B
Enovis (ENOV)	$1.6B
Azenta (AZTA)	$1.6B
Omnicell (OMCL)	$1.3B
Evolent Health (EVH)	$1.2B
Claritev (CTEV)	$719M
Fulgent Genetics (FLGT)	$575M
Standard BioTools (LAB)	$551M
Butterfly Network (BFLY)	$532M
Veradigm (MDRX)	$503M
Talkspace (TALK)	$438M
TruBridge (TBRG)	$347M
Outset Medical (OM)	$345M
Health Catalyst (HCAT)	$282M
Nyxoah SA (NYXH)	$265M
SOPHiA GENETICS SA (SOPH)	$241M
CapsoVision (CV)	$197M
Zepp Health (ZEPP)	$176M
KORU Medical Systems (KRMD)	$164M
Pulmonx (LUNG)	$152M